Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Protein Pept Lett ; 24(7): 590-598, 2017.
Article in English | MEDLINE | ID: mdl-28641565

ABSTRACT

INTRODUCTION: The importance of the antitumor activity of some antimicrobial peptides (AMPs) is being increasingly recognized. The antimicrobial peptide, tachyplesin, has been shown to exhibit anticancer properties and a linear, cysteine deleted analogue (CDT), was found to retain its antibacterial function. OBJECTIVES: The objective was to test CDT and related analogues against normal mammalian, bacterial, and cancer cells to determine their effectiveness and then utilize specific assays to determine a possible mechanism of action. METHODS: We used sequence reversal and D-amino acids to synthesize four CDT analogues by solid phase peptide synthesis. A number of assays were used including liposome dye-leakage, antibacterial activity against both Gram-positive and Gram-negative bacterial strains, hemolytic assays, methyl thiazolyl tetrazolium (MTT), and apoptosis to examine their effectiveness as both AMPs and anti-cancer peptides (ACPs). We then tested the analogues for their ability to inhibit proliferation of the human lung cancer cell line, A549. RESULTS: We found that D-CDT exhibited the best bactericidal properties of those tested and was not damaging to red blood cells. Both D-CDT and reverse D-CDT showed a dose-dependent reduction of cell viability. However, D-CDT was most effective with an IC50 of 9.814 µM, a value 9-fold lower than that calculated for reverse D-CDT (90.16 µM). Apoptosis does not appear to be a mechanism by which D-CDT exerts its anticancer properties since > 100 µM was required to increase activation of caspase 3. Moreover, the ERK1/2 pathway is also unlikely since only a modest (20%) decrease of activity was observed with > 100 µM D-CDT. However, D-CDT was found to operate via a hyaluronan (HA)-dependent mechanism as pretreatment of the cells with hyaluronidase decreased the cytotoxic effects of D-CDT on A549 cells and increased its IC50 29-fold to 283.9 µM. CONCLUSION: D-CDT is both an effective AMP and ACP, and likely exerts its anticancer effects through both membranolytic as well as an HA-mediated mechanism.


Subject(s)
Adenocarcinoma/drug therapy , Antimicrobial Cationic Peptides/administration & dosage , Cell Proliferation/drug effects , DNA-Binding Proteins/administration & dosage , Lung Neoplasms/drug therapy , Peptides, Cyclic/administration & dosage , A549 Cells , Adenocarcinoma/pathology , Adenocarcinoma of Lung , Amino Acid Sequence , Amino Acids/administration & dosage , Amino Acids/chemistry , Antimicrobial Cationic Peptides/chemistry , Apoptosis/drug effects , Cysteine/chemistry , Drug Screening Assays, Antitumor , Gram-Negative Bacteria/drug effects , Humans , Lung Neoplasms/pathology , MAP Kinase Signaling System/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...